標準發展集團(01867.HK)盈警:預期年度虧損不少於約4000萬港元
格隆匯6月11日丨標準發展集團(01867.HK)公吿,根據董事會對集團截至2025年3月31日止財政年度未經審核綜合管理賬目(未經公司獨立核數師及╱或審核委員會審核或審閲)初步審閲,並經考慮董事會目前可取得資料,估計集團本年度將錄得年度虧損不少於約4000萬港元,而截至2024年3月31日止財政年度則錄得年度虧損約2013萬港元。
董事會認為,集團年度預期虧損增加乃主要由於:(i)石油及建築工程相關業務減少導致收入減少;(ii)行政及財務費用增加;及(iii)集團兩個生物天然氣項目尚未產生利潤,乃由於該等項目在第四季度左右才投入運營及生產銷售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.